Raia Drogasil (OTCMKTS:RADLY – Get Free Report) is expected to be announcing its results after the market closes on Tuesday, May 5th. Analysts expect the company to announce earnings of $0.0334 per share and revenue of $2.3620 billion for the quarter.
Raia Drogasil Stock Performance
Shares of RADLY remained flat at $4.70 during trading hours on Monday. The stock had a trading volume of 18,101 shares, compared to its average volume of 18,977. The firm’s 50 day simple moving average is $4.65 and its 200 day simple moving average is $4.49. Raia Drogasil has a 12-month low of $2.17 and a 12-month high of $5.34.
Wall Street Analyst Weigh In
Separately, Zacks Research upgraded Raia Drogasil to a “hold” rating in a research report on Thursday, April 9th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Raia Drogasil currently has a consensus rating of “Hold”.
About Raia Drogasil
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Further Reading
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
